Overview

Exosome Treatment in Androgenetic Alopecia

Status:
COMPLETED

Trial end date:
2024-05-05

Target enrollment:

Participant gender:

Summary

This study aims to elucidate the effect of "foreskin-derived mesenchymal stromal cells derived exosome" injection into the scalp on hair density in patients with androgenetic alopecia and the contribution of this treatment on patient satisfaction.

Phase:

PHASE3

Details

Lead Sponsor:

Yeditepe University Hospital

Treatments:

Exosome Multienzyme Ribonuclease Complex